Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.

Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vellenga E, Holowiecka A, González-Huerta AJ, Fernández P, De la Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM; IC-APL and PETHEMA and HOVON Groups.

Ann Hematol. 2015 Aug;94(8):1347-56. doi: 10.1007/s00277-015-2393-0. Epub 2015 May 15.

PMID:
25975975
2.

Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience.

Diaz-Beveridge R, Lorente D, Torres B, Cañete A, Rodrigo E, Bruixola G, Berlanga P, Reche E, Montalar J, Verdeguer A, Aparicio J.

J Pediatr Hematol Oncol. 2015 Jul;37(5):e278-84. doi: 10.1097/MPH.0000000000000339.

PMID:
25929608
3.

Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: a retrospective study using the Spanish Working Party for BMT in Children (GETMON) database.

Díaz de Heredia C, González M, Verdeguer A, Elorza I, Rodriguez A, Martinez A, Pérez JM, Badell I, Gonzalez ME, Olivé T, Fernández JM, Maldonado MS, Díaz MA, Sánchez de Toledo J.

Bone Marrow Transplant. 2014 Jun;49(6):767-72. doi: 10.1038/bmt.2014.30. Epub 2014 Mar 10.

PMID:
24614843
4.

Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Piñana JL, Sanz J, Picardi A, Ferrá C, Martino R, Barba P, Gonzalez-Vicent M, Pascual MJ, Martín C, Verdeguer A, de Heredia CD, Montesinos P, Ribera JM, Sanz M, Arcese W, Sanz G; GETH groups; GITMO groups.

Haematologica. 2014 Feb;99(2):378-84. doi: 10.3324/haematol.2013.091009. Epub 2013 Oct 4.

5.

Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.

Sanz J, Picardi A, Hernández Boluda JC, Martín C, Ferrá C, Nozzoli C, Gonzalez-Vicent M, Rambaldi A, Valcarcel D, Verdeguer A, Serrano D, de Heredia CD, Pascual MJ, de Paz R, Montesinos P, Bartolozzi B, Algarotti A, Sanz MA, Arcese W, Sanz GF; GETH and GITMO.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1387-92. doi: 10.1016/j.bbmt.2013.07.004. Epub 2013 Jul 11.

6.

Longer follow-up confirms major improvement in outcome in children and adolescents with Philadelphia chromosome acute lymphoblastic leukaemia treated with continuous imatinib and haematopoietic stem cell transplantation. Results from the Spanish Cooperative Study SHOP/ALL-2005.

Rives S, Camós M, Estella J, Gómez P, Moreno MJ, Vivanco JL, Melo M, Fernández-Delgado R, Verdeguer A, Fernández-Teijeiro A, Lendínez F, López-Almaraz R, Uriz JJ, Badell I; Spanish Paediatric Haemato-Oncology Group (SHOP/ SEHOP).

Br J Haematol. 2013 Aug;162(3):419-21. doi: 10.1111/bjh.12373. Epub 2013 May 14. No abstract available.

PMID:
23668628
7.

[T-cell pediatric acute lymphoblastic leukemia: analysis of survival and prognostic factors in 4 consecutive protocols of the Spanish cooperative study group SHOP].

Rives S, Estella J, Camós M, García-Miguel P, Verdeguer A, Couselo JM, Tasso M, Molina J, Gómez P, Fernández-Delgado R, Navajas A, Badell I; grupo cooperativo SHOP (Sociedad Española de Hemato-Oncología Pediátrica).

Med Clin (Barc). 2012 Jul 7;139(4):141-9. doi: 10.1016/j.medcli.2011.12.019. Epub 2012 Mar 28. Spanish.

PMID:
22459573
8.

Institutional experience with clofarabine and cytarabine in relapsed pediatric acute myeloid leukemia.

Moreno L, Fernandez-Navarro JM, Del Mar Andres M, Bautista F, Tasso M, Verdeguer A.

J Pediatr Hematol Oncol. 2012 Jan;34(1):e17-21. doi: 10.1097/MPH.0b013e31820fee1d.

PMID:
21716139
9.

Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005.

Rives S, Estella J, Gómez P, López-Duarte M, de Miguel PG, Verdeguer A, Moreno MJ, Vivanco JL, Couselo JM, Fernández-Delgado R, Maldonado M, Tasso M, López-Ibor B, Lendínez F, López-Almaraz R, Uriz J, Melo M, Fernández-Teijeiro A, Rodríguez I, Badell I.

Br J Haematol. 2011 Sep;154(5):600-11. doi: 10.1111/j.1365-2141.2011.08783.x. Epub 2011 Jun 28.

PMID:
21707583
10.

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.

Barragán E, Montesinos P, Camos M, González M, Calasanz MJ, Román-Gómez J, Gómez-Casares MT, Ayala R, López J, Fuster Ó, Colomer D, Chillón C, Larrayoz MJ, Sánchez-Godoy P, González-Campos J, Manso F, Amador ML, Vellenga E, Lowenberg B, Sanz MA; PETHEMA; HOVON Groups.

Haematologica. 2011 Oct;96(10):1470-7. doi: 10.3324/haematol.2011.044933. Epub 2011 Jun 17.

11.

Evaluation of chimerism by quantitative PCR analysis of DNA polymorphism after allogeneic hematopoietic stem cell transplantation in a pediatric population with malignancies.

Bautista F, Moreno L, Fernández-Navarro JM, Senent L, Andrés MM, Castel V, Verdeguer A.

Pediatr Transplant. 2011 Feb;15(1):81-7. doi: 10.1111/j.1399-3046.2010.01416.x. Epub 2010 Dec 15.

PMID:
21159107
12.

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.

Montesinos P, Rayón C, Vellenga E, Brunet S, González J, González M, Holowiecka A, Esteve J, Bergua J, González JD, Rivas C, Tormo M, Rubio V, Bueno J, Manso F, Milone G, de la Serna J, Pérez I, Pérez-Encinas M, Krsnik I, Ribera JM, Escoda L, Lowenberg B, Sanz MA; PETHEMA; HOVON Groups.

Blood. 2011 Feb 10;117(6):1799-805. doi: 10.1182/blood-2010-04-277434. Epub 2010 Dec 8.

13.

Genetic alterations in children and adolescents with acute myeloid leukaemia.

Verdeguer A.

Clin Transl Oncol. 2010 Sep;12(9):590-6. doi: 10.1007/s12094-010-0563-z.

PMID:
20851799
14.

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

Sanz MA, Montesinos P, Rayón C, Holowiecka A, de la Serna J, Milone G, de Lisa E, Brunet S, Rubio V, Ribera JM, Rivas C, Krsnik I, Bergua J, González J, Díaz-Mediavilla J, Rojas R, Manso F, Ossenkoppele G, González JD, Lowenberg B; PETHEMA and HOVON Groups.

Blood. 2010 Jun 24;115(25):5137-46. doi: 10.1182/blood-2010-01-266007. Epub 2010 Apr 14.

15.

Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience.

Verdeguer A, de Heredia CD, González M, Martínez AM, Fernández-Navarro JM, Pérez-Hurtado JM, Badell I, Gómez P, González ME, Muñoz A, Díaz MA; GETMON: Spanish Working Party for Blood and Marrow Transplantation in Children.

Bone Marrow Transplant. 2011 Jan;46(1):119-24. doi: 10.1038/bmt.2010.52. Epub 2010 Mar 15.

PMID:
20228849
16.

Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).

Muñoz A, Díaz-Heredia C, Badell I, Bureo E, Gómez P, Martínez A, Verdeguer A, Pérez-Hurtado JM, Fernández-Delgado R, González-Vicent M, Maldonado MS.

Pediatr Hematol Oncol. 2009 Jul-Aug;26(5):345-55. doi: 10.1080/08880010902976742.

PMID:
19579081
17.

Diagnosis of paediatric anaplastic large-cell lymphoma: a historical perspective from a single institution.

Moreno L, Garzón L, Bautista FJ, Fernández Navarro JM, András MM, Verdeguer A.

Clin Transl Oncol. 2009 May;11(5):318-21.

PMID:
19451065
18.

Abdominal pain as the first manifestation of primary pancreatic lymphoma.

Bautista F, Moreno L, Andrés Mdel M, Fernández-Navarro JM, Fernández-Sanmartín M, Verdeguer A.

J Pediatr Hematol Oncol. 2009 Mar;31(3):222-3. doi: 10.1097/MPH.0b013e3181979e28. No abstract available.

PMID:
19262254
19.

Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: report from the EBMT Paediatric Diseases and Late Effects Working Parties.

Uderzo C, Pillon M, Tridello G, Dini G, Urban C, Corti P, Zintl F, Fagioli F, Messina C, Verdeguer A, Faraci M, Fedeli S, Tana F, Tichelli A, Passweg J, Rovelli A.

Pediatr Transplant. 2009 Sep;13(6):719-24. doi: 10.1111/j.1399-3046.2008.01055.x. Epub 2008 Sep 26.

PMID:
18992061
20.

Could other viruses cause pediatric posttransplant lymphoproliferative disorder?

Vila L, Moreno L, Andrés MM, Fernández JM, Verdeguer A, Pérez-Valle S, Sangüesa C, Berbel O, Castel V.

Clin Transl Oncol. 2008 Jul;10(7):422-5.

PMID:
18628071

Supplemental Content

Loading ...
Support Center